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Abstract
Background: The COVID-19 pandemic has likely had a negative impact on rehabilitation and quality of
life (QoL) research in multiple sclerosis (MS).
Method: We explored perceived barriers to research among 87 researchers, representing 18 countries,
both prior to and since COVID-19.
Results: A Wilcoxon signed-rank test found that significantly more researchers reported experiencing
barriers to research since the onset of the pandemic compared to pre-COVID-19 (p< .001), with 78% of
respondents reporting at least some barriers since COVID-19. The most commonly-cited barriers related
to participant access (n¼ 38) and interruptions/delays to projects (n¼ 19). Although no gender differ-
ences were found in the number of barriers reported, female respondents were more likely to cite time or
competing demands as barriers to research. Females were also more likely to perceive being negatively
impacted by the pandemic compared to other genders (p¼ .007).
Conclusions: Implications for the future landscape of rehabilitation research in MS are discussed.
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Introduction
The COVID-19 pandemic has impacted almost all
researchers,1 with more detrimental effects on some
research programmes compared to others. While much
work has established how the management of multiple
sclerosis (MS) has changed in the last year,2 with a
shift towards virtual consultations,3,4 the impacts of
COVID-19 on MS research are less understood. In
the context of MS, research in the field of rehabilita-
tion and quality of life (QoL) is likely to have been
particularly affected given the high reliance on face-
to-face data collection and intervention delivery.
In this study, we aimed to explore the barriers
encountered by researchers working in rehabilitation
and QoL research in MS, both prior to and since the
COVID-19 pandemic. We further explored whether
barriers varied by gender, given the known disad-
vantage of female researchers in other domains.5,6
Understanding the challenges faced by researchers
is important when anticipating the future of rehabil-
itation research and interventions designed to sup-
port people with MS (PwMS).
Method
Sample
MS QoL and/or rehabilitation researchers were invit-
ed to participate in the study in January-February
2021 via professional bodies and through networks
of members of the International Women in MS
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rehabilitation (IWiMS) group, using a mixture of pur-
posive and snowball sampling. Specifically, invita-
tions were sent to professional contacts of the study
authors and to other members of the rehabilitation
subgroup of IWiMS. Examples of groups contacted
were: members of the euRIMS (Rehabilitation in MS)
special interest group in mobility, the euRIMS special
interest group in occupation, the All-Ireland MS
Research Network, rehabilitation researchers who
attended the MS Society of Canada 2019 conference,
members of various MS research groups in Austria,
Belgium, Finland, Turkey, the UK, Switzerland and
Germany, among others, and a wide range of rehabil-
itation researchers, physiotherapists, physicians, and
other allied health professional researchers known to
the authors. While invitations were mostly made via
email, additional vocal invitations were made during
remote meetings of certain research groups. Further
calls for participants were made using Twitter, with
tweets shared among the followers of relevant net-
works and MS societies. In order to be eligible to
participate, respondents had to have conducted
research in the area of MS rehabilitation or QoL.
No restrictions were placed on career stage or
nature of employment. Ethical approval for the
study was granted from Maynooth University in
December 2020 (SRESC-2020-2422005).
Measures
A cross-sectional online survey was developed to col-
lect quantitative and qualitative data from researchers
using Qualtrics, v.2021 (Qualtrics, Provo, UT). This
included the collation of sociodemographic informa-
tion such as gender (male, female, non-binary, other),
country of residence (open text response) and
employment status (full-time or part-time, and con-
tract type). In addition, information on career stage
was obtained, with respondents asked to indicate if
they were (1) still in training, (2) an early-career
researcher (5 years or less since their first research/
academic appointment), (3) a mid-career researcher
(6-12 years since first appointment), (4) a senior
researcher (>12 years since first appointment), or
(5) other. Respondents also indicated the number of
years’ experience they had in MS research using an
open-text response, as well as the percentage of their
working time spent of research activities each week.
Separately, respondents were asked to indicate if they
had any caring responsibilities.
In relation to their experience of barriers to research,
researchers were asked to report on the extent of
barriers encountered both prior to and since
COVID-19. Specifically, they were asked “Before
COVID-19, did you encounter any barriers in con-
ducting research in rehabilitation/QOL in MS?”,
with four possible options: “Yes, to a great extent”,
“Yes, to some extent”, “No”, and “Unsure”, with the
latter two categories combined for the purpose of
analysis, such that scores ranged from 1–3, with
higher scores denoting a greater experience of bar-
riers. An open-text question requested more detail on
barriers from respondents using the following phras-
ing: “If yes, outline the main barriers to conducting
research before COVID-19”. The same two ques-
tions were then asked again, but in relation to expe-
rience of barriers since COVID-19.
In order to establish perceptions of gender advan-
tage/disadvantage in light of COVID-19, respond-
ents were asked to rate their agreement with the
following statement “When compared to researchers
of other genders, I have experienced greater difficul-
ties in conducting research in MS rehabilitation/QoL
following COVID-19”, with responses ranging from
1 (strongly disagree) to 5 (strongly agree). Further
details on all the above questions are included in the
supplementary appendix.
Analysis
Descriptive statistics were calculated for sociodemo-
graphic/employment information and extent of bar-
riers encountered prior to and since COVID-19.
Given the non-normal distribution of the data, a
Wilcoxon signed-ranks test was used to compare
the extent of the barriers experienced by researchers
prior to and since COVID-19. Barriers described in
response to the open-text questions were categorised
independently by two coders (RM, SH), with a high
level of agreement (88%); any discrepancies were
resolved with input from a third coder (BS). Where
respondents mentioned more than one barrier, these
were separately coded. Following categorisation into
broad themes, additional subthemes were identified
(Table 1). Independent t-tests were used to compare
gender differences in the number of barriers men-
tioned both prior to and since COVID-19, with a
further independent-test test used to compare male
and female perceptions of gender advantage or dis-
advantage in light of COVID-19.
Results
Sample characteristics
Of the 87 respondents, the majority were female
(66, 76%), working full-time (74, 85%), at
mid-late career stage (53, 61%), and had an
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“It is getting increasingly difficult to get third party funded money for
research in MS.”
“Funders say they are interested in QoL, but still tend to fund basic science
as a priority.”
“Less sponsors compared to other fields, sometimes the H index is required.
It is somewhat unfair.”
Time/competing
responsibilities




“Difficult to balance research obligations with other commitments.”
Teaching “I work in an education heavy institution with little time allowed for
research.”
“Competing obligations such as teaching, curriculum development, board
services, etc.”
Clinical work “I work in a clinical specialist role so the majority of my time is clinical. Only
small amount of time for research projects.”
Caring
responsibilities
“Many positions are full time and with my caring role couldn’t commit to full
time.”
“The travel time commitment to scientific meetings was a problem, as I need
to have child care organized before any trip.”
Lack of support/
opportunity





“Logistical barriers in terms of recruiting students and staff. Equipment and
space limitations.”
“Bureaucracy and institutional inertia”.
Lack of collabora-
tive opportunities




“Many disease specific journals do not consider rehabilitation studies high
enough impact to publish.”
Gender or career
bias
“Hard to gain independence, to be taken “seriously” by the established male
old guard in the field.”
“Male doctors in high positions preferred to work with male researchers.”
“. . .a sense of fear among early and mid-career investigators of senior
investigators taking credit for work/ideas.”
Participant access




“Difficulties with subject recruitment and retention”
“Access to MS population in rural communities.”
Competition for
participants
“There are many researchers focused on MS at my institution, so there is a














“Significant restrictions on human subjects research.”
“Poor accessibility to patients.”
“COVID related restrictions mean that I cannot bring in patients to the lab





rehabilitation/QoL research (SD¼ 7.3, range 1–
30 years). Respondents came from 18 different coun-
tries, including the USA (n¼ 24), Italy (n¼ 16),
Canada (n¼ 10), Austria (n¼ 9), France (n¼ 4), the
UK (n¼ 3), Turkey (n¼ 3), Ireland (n¼ 3), Belgium
(n¼ 3), Norway (n¼ 2), Switzerland (n¼ 1), Spain
(n¼ 1), Slovenia (n¼ 1), Israel (n¼ 1), Germany
(n¼ 1), Finland (n¼ 1), the Czech Republic (n¼ 1),
and Australia (n¼ 1). On average, respondents spent
57% (SD¼ 25.8) of their working week engaged in
research. Most (50, 59%) reported some caring
responsibilities.
Barriers to research
A Wilcoxon signed-rank test found that respondents
were significantly more likely to report experiencing
barriers since COVID-19 (M¼ 2.18) than pre-
COVID-19 (M¼ 1.61; T¼ 1314, z¼5.372,
p< .001), with only 22% (n¼ 18) reporting no bar-
riers since COVID-19, while 39% (n¼ 32) reported
barriers “to some extent” and a further 39% (n¼ 32)
experiencing barriers “to a great extent”. This com-
pares to only 6% (n¼ 7) who reported barriers “to a
great extent” prior to COVID-19 (see Figure 1).
Of respondents who chose to complete an open text
response, significantly more barriers were mentioned
since COVID-19 (total n mentioned¼ 83) than pre-
COVID-19 (total n mentioned¼ 57; T¼ 808,
z¼2.765, p¼ .006). Independent t-tests found no
gender differences in the number of barriers mentioned
at either time point (p> .05), however females
Table 1. Continued.
Fear of COVID “increased difficulty recruiting patients for studies that require in-person
visits due to fear of contracting COVID.”
Barriers since COVID-19
Superordinate barri-
er since COVID Subordinate barrier Representative quotes
Interruptions or
delays (n¼ 19;
male ¼ 7, female
¼ 12)
Projects interrupted “Projects were disrupted in the middle of delivery and this will impact overall
results.”
“My research requires close proximity. As such, my main project is shut
down for the foreseeable future.”
Closure of facilities “Difficulties to do testing in the center, or to have permission to conduct tests
at our university.”




“Slower response time from ethic committee when not a specific COVID
related project”
“. . .non-COVID-19 research is being sidelined and there have been longer
processing and review times.”
Time/competing
demands (n¼ 11;




“Even more difficult to dedicate sufficient time to research, especially given
additional responsibilities with caring/home-schooling.”
“Home schooling make it more challenging to complete work in usual hours
therefore I work extra in my own time to get everything completed.”
“Spending more time facilitating at home learning and providing childcare
while schools were closed also significantly impacted my research.”
Other
responsibilities
“Too many administrative and clinical responsibilities which interfere with
research time”
Funding (n¼ 8;




“The usual funding competitions in my field were cancelled.”
“Charitable body funding no longer currently available.”
Additional COVID-
19 challenges
(n¼ 7; male ¼ 1,
female ¼ 6)
Working remotely “inability to get the research team together - there are limits to virtual col-
laboration for some activities.”
“Hard to maintain focus and motivation working full time from home.”
“..having research assistants has not been helpful since COVID-19 as many
tasks are not able to be completed virtually with confidentiality of research
data so they are not able to help very much with many of the important
tasks.”
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(M¼ 3.11, SD¼ 1.13) were significantly more likely
than males (M¼ 2.32, SD¼ .95) to perceive them-
selves as experiencing difficulties conducting research
in MS rehabilitation/QoL following COVID-19 when
compared to other genders (t(79)¼2.782; p¼ .007).
Analysis of the open-text response revealed that,
prior to COVID-19, the most commonly mentioned
barriers were difficulty obtaining funding (n¼ 19),
managing time/competing demands (n¼ 15), and
lack of support/opportunity (n¼ 15). Since
COVID-19, the most common barriers encountered
related to participant access (n¼ 38), and other
COVID-19 interruptions/delays to research projects
(n¼ 18). Time/competing demands was mentioned
by 11 respondents, all female, including some men-
tions of childcare and home-schooling responsibili-
ties (see Table 1 for representative quotes).
Discussion
Our analysis clearly highlights the negative impact
that the COVID-19 pandemic has had on MS reha-
bilitation/QoL research. Unsurprisingly, limited
access to participants was common, with numerous
reports of trials being halted or delayed. Barriers to
participant access were found to stem from logistical
issues (e.g., closure of facilities), or participant char-
acteristics themselves (e.g., fear of contracting
COVID-19). Given that anxiety in PwMS has
increased following the pandemic,7,8 difficulty
accessing participants may persist for some time,
however it is yet to be established whether this
may be mitigated by the vaccine roll out.
Furthermore, as much research in this field had to
pivot to online delivery, it cannot yet be established
whether this may have had any impacts on enhanc-
ing QoL in PwMS. Given the success of telemedi-
cine and virtual consultations in the clinical
management of MS,3,4 there is a clear need to further
evaluate the efficacy of online rehabilitation inter-
ventions, which may offer a promising alternatives
to face-to-face intervention delivery. Regardless of
this, however, the lack of preliminary data due to the
interruption of pilot trials during the pandemic may
have long lasting implications for future funding and
dissemination of knowledge in this area, ultimately
impacting service provision for PwMS.
While we found no gender differences in the number
of barriers reported by respondents, our qualitative
analysis suggests subtle differences in the types of
barriers encountered. For example, only female
respondents cited time or competing demands as
barriers since COVID-19. We also uncovered some
concerning reports of possible gender or career
biases that may impede the progression of female
and/or early career researchers in the future. While
this is partly in keeping with other research which
has suggested how the pandemic has disproportion-
ally affected female researchers,5,6 we cannot draw
firm conclusions regarding gendered effects in this
research context specifically. We suggest that this is
something worth closely monitoring in the future,
particularly regarding whether COVID-19 related
interruptions may manifest into lower research out-
puts for female researchers in the coming years.
Limitations
Although we contacted many research networks
worldwide, we cannot be assured that the sample
represents the diversity of MS researchers in the
field of rehabilitation and QoL. We also cannot be
sure of the response rate to this survey, given the
nature of the recruitment strategy employed.
Additionally, the cross-sectional design warrants
caution when interpreting the retrospective analysis
of barriers prior to COVID-19.
Conclusions
While the existence of barriers to research following
COVID-19 echoes findings from other fields,1,9
including reports of widespread closure of facilities
and limitations accessing funding, we have shown
how a number of unique challenges exist for MS
rehabilitation/QoL research specifically, including
many that existed prior to the pandemic and which
therefore may be expected to continue should face-to-
face research recommence. Given the call to prioritize
areas of research supporting people with progressive
MS in particular,10 it is vital that any barriers to
research in the area of rehabilitation and QoL are
tackled. It is also important that such obstacles are





























Pre COVID-19 Since COVID-19
Figure 1. The extent to which respondents experienced
barriers to research prior to and since COVID-19.a
aBarriers more likely to be experienced since COVID-19
compared to pre COVID-19, using Wilcoxon signed-rank
test (T¼1314, z¼ –5.372, p< .001).
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researchers over the coming years, which will in turn
have implications for the successful symptom man-
agement and wellbeing of PwMS.
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